Primer-probes for the quantification of baseline RNA levels of TAP, CPA1, CPA2, amylase,
lipase and two endogenous controls, PUM and GUS in tissue were purchased from Thermo Fisher Scientific (Waltham, MA, USA). TAP (Gene: Prss1; Assay: Rn00754931_m1; cat#4331182), CPA1 (Gene: CPA1; Assay: Rn00566512_m1; cat#4331182), CPA2 (Gene: CPA2, Assay: Rn01500585_m1; cat#4331182), amylase (Gene: Amy2a3; Assay: Rn00821330_g1; cat#4331182), pancreatic
lipase (Gene: Pnlip; Assay: Rn00565851_m1; cat#4331182), PUM (Rn00982780_m1; cat# 4331182 ), GUSB (Rn00566655_m1; cat# 4331182). RNA from duodenum, liver and salivary gland was extracted using a
Magmax liquid handler and the
Magmax™-96 for Microarrays Total RNA Isolation Kit (all Thermo Fisher Scientific Waltham, MA, USA). Pancreas RNA was extracted with a trizol/chloroform/isopropanol precipitation method to avoid RNA degradation. Reverse transcription of 500 ng total RNA was performed in a 100 µL final volume with the
High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, cat # 4368814) on a Proflex instrument (Thermo Fisher Scientific). Quantitative PCR was performed in triplicate on a
Quantstudio 12K Flex in a final volume of 10 µL with 5 µL of
2x Mastermix (Thermo Fisher Scientific cat#4324020), 0.5 µL of 20x Assay on demand (primer-probes) and 2.5 µL water.
Vlasakova K., Steinhilber A., Bailey W.J., Erdos Z., Haag H., Joos T., Ackermann B.L., Poetz O, & Glaab W.E. (2022). Plasma biomarkers TAP, CPA1, and CPA2 for the detection of pancreatic injury in rat: the development of a novel multiplex IA-LC-MS/MS assay and biomarker performance evaluation. Archives of Toxicology, 97(3), 769-785.